Lilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bnLilly buys AtaiBeckley·$3.8bnOtsuka buys Transcend·$1.2bnAbbVie buys Gilgamesh·$1.2bnatai buys Beckley Psytech·terms undisclosedAbbVie takes an option on Gilgamesh·$2bn
Next issueIssue 16 · Tue 29 Sep 

Companies

atai

atai Life Sciences N.V.

HQ
Netherlands
Status
renamed
Listing
Listed · ATAI

sec.govregistryverified 2026-09-25

Notes on the record

Acquirer in D002-atai-beckley-psytech-2025, the all-share purchase of Beckley Psytech Limited. A Dutch N.V., the listed parent at the time of that deal; the deal row records it as renamed Atai Beckley N.V. on completion. Added 2026-09-25 so the deal tape can print its short name; this row asserts nothing about the later corporate history, which D001 and C001 carry.

Assets

No asset in data/assets.csv names this company as owner.

Registered trials

No row in data/trials.csv resolves to this company's assets.

Deals

This company is not a party to any row in data/deals.csv.

In the briefing

No published issue carries the ATAI-LIFE-SCIENCES tag.